Education
About Us
Working with TipRanks
Follow Us
Omega Diagnostics Group PLC (GB:CNSL)
LSE:CNSL
Total Valuation
Omega Diagnostics has a market cap or net worth of £7.73M. The enterprise value is 5.29M.
Market Cap£7.73M
Enterprise Value5.29M
Share Statistics
Omega Diagnostics has 237,950,650 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding237,950,650
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Omega Diagnostics’s return on equity (ROE) is -0.03 and return on invested capital (ROIC) is -1.89%.
Return on Equity (ROE)-0.03
Return on Assets (ROA)-0.02
Return on Invested Capital (ROIC)-1.89%
Return on Capital Employed (ROCE)-0.04
Revenue Per Employee103.98K
Profits Per Employee-3.49K
Employee Count94
Asset Turnover0.70
Inventory Turnover6.14
Valuation Ratios
The current PE Ratio of Omega Diagnostics is -24.64. Omega Diagnostics’s PEG ratio is 0.26.
PE Ratio-24.64
PS Ratio0.00
PB Ratio0.83
Price to Fair Value0.83
Price to FCF14.75
Price to Operating Cash Flow13.32
PEG Ratio0.26
Income Statement
In the last 12 months, Omega Diagnostics had revenue of 9.77M and earned -328.00K in profits. Earnings per share was 0.00.
Revenue9.77M
Gross Profit6.05M
Operating Income-535.00K
Pretax Income-745.00K
Net Income-328.00K
EBITDA-73.00K
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was 737.00K and capital expenditures -175.00K, giving a free cash flow of 562.00K billion.
Operating Cash Flow737.00K
Free Cash Flow562.00K
Free Cash Flow per Share<0.01
Dividends & Yields
Omega Diagnostics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.86
52-Week Price Change-13.33%
50-Day Moving Average2.83
200-Day Moving Average3.19
Relative Strength Index (RSI)79.65
Average Volume (3m)153.34K
Important Dates
Omega Diagnostics upcoming earnings date is Jul 22, 2025, TBA Not Confirmed.
Last Earnings DateNov 21, 2024
Next Earnings DateJul 22, 2025
Ex-Dividend Date―
Financial Position
Omega Diagnostics as a current ratio of 4.67, with Debt / Equity ratio of 1.53%
Current Ratio4.67
Quick Ratio4.31
Debt to Market Cap0.02
Net Debt to EBITDA38.29
Interest Coverage Ratio-24.32
Taxes
In the past 12 months, Omega Diagnostics has paid -417.00K in taxes.
Income Tax-417.00K
Effective Tax Rate0.56
Enterprise Valuation
Omega Diagnostics EV to EBITDA ratio is -72.43, with an EV/FCF ratio of 9.65.
EV to Sales0.54
EV to EBITDA-72.43
EV to Free Cash Flow9.65
EV to Operating Cash Flow8.71
Balance Sheet
Omega Diagnostics has £4.52M in cash and marketable securities with £79.00K in debt, giving a net cash position of -£4.44M billion.
Cash & Marketable Securities£4.52M
Total Debt£79.00K
Net Cash-£4.44M
Net Cash Per Share-£0.02
Tangible Book Value Per Share£0.02
Margins
Gross margin is 61.86%, with operating margin of -5.47%, and net profit margin of -3.36%.
Gross Margin61.86%
Operating Margin-5.47%
Pretax Margin-7.62%
Net Profit Margin-3.36%
EBITDA Margin-0.75%
EBIT Margin-7.40%
Analyst Forecast
The average price target for Omega Diagnostics is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―